Episode 6: Psychiatric drugs: Symptomatic versus disease-modifying - podcast episode cover

Episode 6: Psychiatric drugs: Symptomatic versus disease-modifying

Jul 07, 202218 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

I discuss my recent article defining psychiatric drugs in two categories: those that improve symptoms and those that affect the underlying disease process. Most psychiatric drugs are symptomatic, and not disease-modifying, and thus should be used less and short-term, in my view. Disease modifying drugs should be used more and long-term. They include lithium and other mood stabilizers.  


The article has generated some discussion on the internet, including some claims with which I don't agree. 


The podcast describes and clarifies the concept. 


The article can be found here:


https://onlinelibrary.wiley.com/doi/abs/10.1111/acps.13459





---

Support this podcast: https://podcasters.spotify.com/pod/show/nassir-ghaemi/support

Get full access to The Psychiatry Letter at ghaemi.substack.com/subscribe
For the best experience, listen in Metacast app for iOS or Android